PD
ADPT icon

Point72 (DIFC)’s Adaptive Biotechnologies ADPT Stock Holding History

Point72 (DIFC)’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-19,637
Closed -$101K – 1480
2024
Q3 		$101K Buy
+19,637
New +$85.6K ﹤0.01% 975
2024
Q2 		– Sell
-11,731
Closed -$37.7K – 1423
2024
Q1 		$37.7K Buy
+11,731
New +$45.4K ﹤0.01% 1236

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Point72 (DIFC)'s ADPT Position: Q4 2024 in Review

Point72 (DIFC) sold out of Adaptive Biotechnologies (ADPT) in Q4 2024, closing a stake of 19,637 shares — an estimated $101K sold.

Point72 (DIFC) first reported a position in ADPT in Q1 2024 and held it in 2 quarters. The position peaked at $101K in Q3 2024. 207 funds tracked by Wall St. Rank hold ADPT as of Q4 2024.

  • Point72 (DIFC) reported no remaining Adaptive Biotechnologies position as of Q4 2024 after selling out during the quarter.
  • Point72 (DIFC) sold 19,637 Adaptive Biotechnologies shares in Q4 2024, an estimated $101K.
  • Point72 (DIFC) first reported a position in Adaptive Biotechnologies in Q1 2024 and held it in 2 quarters.
  • Point72 (DIFC)'s Adaptive Biotechnologies position peaked at $101K in Q3 2024.
  • 207 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q4 2024.

Based on Point72 (DIFC)'s 13F filing for Q4 2024, filed 14 Feb 2025.